A 12 week prospective placebo controlled RCT, initially showed a marginally significant benefit with varenicline at the end of 12 weeks which did not sustain at the end of 24 weeks.
1
—
—
A 12 week prospective placebo controlled RCT, initially showed a marginally significant benefit with varenicline at the end of 12 weeks which did not sustain at the end of 24 weeks.